Skip to main content
PLOS One logoLink to PLOS One
. 2015 Jun 1;10(6):e0129639. doi: 10.1371/journal.pone.0129639

Correction: Enhancing Anti-Tumor Efficacy of Doxorubicin by Non-Covalent Conjugation to Gold Nanoparticles - In Vitro Studies on Feline Fibrosarcoma Cell Lines

Michał Wójcik, Wiktor Lewandowski, Magdalena Król, Karol Pawłowski, Józef Mieczkowski, Roman Lechowski, Katarzyna Zabielska
PMCID: PMC4452618  PMID: 26030279

The images for Figs 5 and 6 are incorrectly switched. The image that appears as Fig 5 should be Fig 6, and the image that appears as Fig 6 should be Fig 5. The figure captions appear in the correct order.

Fig 5. Correlation between cell viability (as measured with MTT assay) and chemotherapeutic dose.

Fig 5

Analysis for (a) FFS1WAW, (b) FFS1, (c) FFS3 and (d) FFS5 cell lines. Red and black lines represent Dox and Au-GSH-Dox doses, respectively.

Fig 6. The effect of tested substances (Au-GSH, Dox, Au-GSH-Dox) on apoptosis and necrosis of each cell line: (a) FFS1WAW, (b) FFS1, (c) FFS3.

Fig 6

Tested substances were given at concentrations based on the MTT assay results. Statistical analysis was performed using Prism version 5.00 software (GraphPad Software, USA). Unpaired t-test was used, p<0,05 was described as *, p<0.01 was marked as **, p<0.001 was marked as ***

Reference

  • 1. Wójcik M, Lewandowski W, Król M, Pawłowski K, Mieczkowski J, Lechowski R, et al. (2015) Enhancing Anti-Tumor Efficacy of Doxorubicin by Non-Covalent Conjugation to Gold Nanoparticles—In Vitro Studies on Feline Fibrosarcoma Cell Lines. PLoS ONE 10(4): e0124955 doi: 10.1371/journal.pone.0124955 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from PLoS ONE are provided here courtesy of PLOS

RESOURCES